Several natural products (NPs) have displayed varying in vitro activities against methicillinresistant Staphylococcus aureus (MRSA). However, few of these compounds have not been developed into potential antimicrobial drug candidates. This may be due to the high cost and tedious and time-consuming process of conducting the necessary preclinical tests on these compounds. In this study, cheminformatic profiling was performed on 111 anti-MRSA NPs (AMNPs), using a few orally administered conventional drugs for MRSA (CDs) as reference, to identify compounds with prospects to become drug candidates. This was followed by prioritizing these hits and identifying the liabilities among the AMNPs for possible optimization. Cheminformatic profilin...
Drug resistant bacterial infections are an increasing threat to human health across the globe. Curre...
The serious challenge posed by multidrug-resistant bacterial infections with concomitant treatment f...
The global prevalence of antibacterial resistance requires new antibacterial drugs with novel chemic...
Several natural products (NPs) have displayed varying in vitro activities against methicillin-resist...
Several natural products (NPs) have displayed varying in vitro activities against methicillin-resist...
Magister Pharmaceuticae - MPharmThe growing resistance of Methicillin-Resistant Staphylococcus aureu...
>Magister Scientiae - MScThe growing resistance of Methicillin-Resistant Staphylococcus aureus (MRSA...
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major causes for nosocomial infecti...
Financial support from Fundacao para a Ciencia e Tecnologia (FCT) Portugal, under Project PTDC/QUIQU...
Methicillin-resistant Staphylococcus aureus (MRSA) is a drug-resistant bacterium that can cause a ra...
Methicillin resistant Staphylococcus aureus (MRSA) has emerged as a dreadful pathogen causing broad ...
The global prevalence of antibacterial resistance requires new antibacterial drugs with novel chemic...
Drug resistance developed in human pathogenic bacteria is emerging and has become a global problem. ...
Drug resistance developed in human pathogenic bacteria is emerging and has become a global problem. ...
Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat for effective treatmen...
Drug resistant bacterial infections are an increasing threat to human health across the globe. Curre...
The serious challenge posed by multidrug-resistant bacterial infections with concomitant treatment f...
The global prevalence of antibacterial resistance requires new antibacterial drugs with novel chemic...
Several natural products (NPs) have displayed varying in vitro activities against methicillin-resist...
Several natural products (NPs) have displayed varying in vitro activities against methicillin-resist...
Magister Pharmaceuticae - MPharmThe growing resistance of Methicillin-Resistant Staphylococcus aureu...
>Magister Scientiae - MScThe growing resistance of Methicillin-Resistant Staphylococcus aureus (MRSA...
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major causes for nosocomial infecti...
Financial support from Fundacao para a Ciencia e Tecnologia (FCT) Portugal, under Project PTDC/QUIQU...
Methicillin-resistant Staphylococcus aureus (MRSA) is a drug-resistant bacterium that can cause a ra...
Methicillin resistant Staphylococcus aureus (MRSA) has emerged as a dreadful pathogen causing broad ...
The global prevalence of antibacterial resistance requires new antibacterial drugs with novel chemic...
Drug resistance developed in human pathogenic bacteria is emerging and has become a global problem. ...
Drug resistance developed in human pathogenic bacteria is emerging and has become a global problem. ...
Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat for effective treatmen...
Drug resistant bacterial infections are an increasing threat to human health across the globe. Curre...
The serious challenge posed by multidrug-resistant bacterial infections with concomitant treatment f...
The global prevalence of antibacterial resistance requires new antibacterial drugs with novel chemic...